Ovid Therapeutics Statistics
Total Valuation
OVID has a market cap or net worth of $21.94 million. The enterprise value is -$6.86 million.
Important Dates
The last earnings date was Tuesday, May 13, 2025, before market open.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OVID has 71.11 million shares outstanding. The number of shares has increased by 0.50% in one year.
| Current Share Class | 71.11M |
| Shares Outstanding | 71.11M |
| Shares Change (YoY) | +0.50% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 5.61% |
| Owned by Institutions (%) | 41.39% |
| Float | 50.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 39.55 |
| Forward PS | 56.38 |
| PB Ratio | 0.37 |
| P/TBV Ratio | 0.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.93, with a Debt / Equity ratio of 0.24.
| Current Ratio | 4.93 |
| Quick Ratio | 4.62 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -64.02 |
Financial Efficiency
Return on equity (ROE) is -36.31% and return on invested capital (ROIC) is -39.90%.
| Return on Equity (ROE) | -36.31% |
| Return on Assets (ROA) | -31.37% |
| Return on Invested Capital (ROIC) | -39.90% |
| Return on Capital Employed (ROCE) | -73.97% |
| Revenue Per Employee | $23,826 |
| Profits Per Employee | -$1.06M |
| Employee Count | 23 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.55% in the last 52 weeks. The beta is 0.27, so OVID's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | -90.55% |
| 50-Day Moving Average | 0.35 |
| 200-Day Moving Average | 0.83 |
| Relative Strength Index (RSI) | 46.07 |
| Average Volume (20 Days) | 401,179 |
Short Selling Information
The latest short interest is 1.34 million, so 1.88% of the outstanding shares have been sold short.
| Short Interest | 1.34M |
| Short Previous Month | 1.20M |
| Short % of Shares Out | 1.88% |
| Short % of Float | 2.66% |
| Short Ratio (days to cover) | 2.76 |
Income Statement
In the last 12 months, OVID had revenue of $548,000 and -$24.34 million in losses. Loss per share was -$0.34.
| Revenue | 548,000 |
| Gross Profit | 548,000 |
| Operating Income | -53.52M |
| Pretax Income | -50.68M |
| Net Income | -24.34M |
| EBITDA | -52.90M |
| EBIT | -53.52M |
| Loss Per Share | -$0.34 |
Full Income StatementBalance Sheet
The company has $43.00 million in cash and $14.43 million in debt, giving a net cash position of $28.57 million or $0.40 per share.
| Cash & Cash Equivalents | 43.00M |
| Total Debt | 14.43M |
| Net Cash | 28.57M |
| Net Cash Per Share | $0.40 |
| Equity (Book Value) | 59.28M |
| Book Value Per Share | 0.83 |
| Working Capital | 36.61M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$49.55 million and capital expenditures -$52,000, giving a free cash flow of -$49.60 million.
| Operating Cash Flow | -49.55M |
| Capital Expenditures | -52,000 |
| Free Cash Flow | -49.60M |
| FCF Per Share | -$0.70 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -9,766.06% |
| Pretax Margin | -4,557.30% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OVID does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.50% |
| Shareholder Yield | -0.50% |
| Earnings Yield | -112.11% |
| FCF Yield | -228.48% |
Analyst Forecast
The average price target for OVID is $3.03, which is 882.17% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.03 |
| Price Target Difference | 882.17% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 171.98% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OVID has an Altman Z-Score of -4.35 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.35 |
| Piotroski F-Score | 1 |